Drug Repurposing Flubendazole to Suppress Tumorigenicity via PCSK9-dependent Inhibition and Potentiate Lenvatinib Therapy for Hepatocellular Carcinoma

Wenjiao Jin(Renji Hospital), Hong Li(Renji Hospital)
International Journal of Biological Sciences
January 1, 2023
Cited by 19


Related Papers